Webinar Recording: Product Launch Supply Chain Milestones and post-Brexit considerations
Date of webinar: Thursday 25th June 2020
This webinar will provide an overview of key supply chain milestones and post-Brexit considerations for planning your EU supply chain strategy. Emma Jordan, Logistics Manager, will apply her wealth of experience and highlight some of the practical considerations of setting up your supply chain to get your drug to market. From examining finance and customs, the various supply chain models and even the regulations that govern your supply chain.
Reviewing the ‘Northern Ireland Protocol’, a key part of the UK’s Withdrawal Agreement with the EU, Ivan Waide (Corporate Counsel, Almac Group) will provide insight into the Protocol, how it puts Almac’s global headquarters in Craigavon, Northern Ireland, in a unique position (with access to both the EU and UK markets) and its impact on the supply chain and movement of pharmaceutical drug products within Northern Ireland, the UK and the European Union. These key supply chain and post-Brexit considerations will ensure you are adequately prepared for a successful product launch upon MA approval.
Almac Pharma Services provide a wide range of customised commercial services from supporting product launch, manufacturing and / or packaging drug product, to securing supply chain with global serialisation solutions.
Our flexible, quality-led commercial solutions range from orphan drug launches to ongoing high-volume commercial product manufacture, packaging and supply.